Last week, BioReperia was proud to take part in the very firstTumor Models Nordic meeting in Stockholm, an event that brought together leading scientists, clinicians, and industry experts working with preclinical cancer models.
The meeting provided an excellent platform to share insights and discuss the latest advancements in tumor modeling and translational research. BioReperia contributed by showcasing our zebrafish-based tumor models and how they enable faster and more predictive cancer drug screening.
We were excited to engage in meaningful discussions about the future of personalized medicine and the role of innovative in vivo models in accelerating oncology research.
